NVO
Novo Nordisk A/S (NVO) Stock Analysis
OMX NORDIC EXCHANGE COPENHAGEN A/S · Pharmaceuticals
$43.24
▲ +0.12%
Finnhub quote · as of Sep 18, 2026, 4:00 PM ET · no synthetic replacement
$43.50
Open
$43.54
High
$42.78
Low
$43.19
Prev close
$1.21T
Market cap
Analyze NVO in depth →
Guests get 2 analyses/day. Create a free account for 5/day.
What you get with ImpliedLens
Financial statements
Income, balance sheet, cash flow from SEC filings with 30+ calculated ratios.
DCF valuation
Customizable discounted cash flow model with live inputs.
Analyst targets
Price targets, recommendation breakdowns, earnings surprises.
Institutional context
Ownership data and aggregated FINRA OTC activity.
SEC filings
Direct links to 10-K, 10-Q, 8-K, and proxy statements.
Projection models
Bull/base/bear scenario modeling with editable assumptions.
Questions to answer before investing in NVO
01Which products and pipeline milestones drive Novo Nordisk A/S's next five years of cash flow?
02Which risks would invalidate the investment thesis for NVO?
03How does NVO's valuation compare with its growth, quality, and closest alternatives?